Medical Hypotheses
Volume 58, Issue 3 , Pages 225-228, March 2002

Optimum inorganic ion concentrations for hematopoiesis cultures

University of Rochester, Rochester, NY, USA

Received 5 February 2001; accepted 5 July 2001.

Abstract 

Current limitations in the ability to culture hematopoietic cells may be due to the use of ion concentrations that reflect those in the general circulation rather than those expected at hematopoietic sites. Expected changes in calcium, phosphate and hydroxyl ion are calculated indirectly using published data. Results indicate doubling of normal concentrations for the first week, followed by 2 weeks of smaller elevations as the osteon undergoes resorption and replacement. The period of 3 weeks fits the expected time of the three stages of differentiation and proliferation of erythrocytes to the maturation phase. Mimicking the high concentrations of these ions in vitro may require the development of dynamic flow cultures because of problems with precipitation of calcium phosphate crystals. After 3 weeks 10% less than normal concentrations is expected as the bone mineral is replaced over a period of months, allowing a static system for maturation.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • f1 Correspondence to: Donald R. Taves MD, PhD, 10901 176th Circle NE. 3516, Redmond, WA 98052, USA. Phone: +1 425 885 7027 (home); 360 336 3721 (office); Fax: +1 425 556 8128; E-mail: taves@aol.com

PII: S0306-9877(01)91464-1

doi:10.1054/mehy.2001.1464

Medical Hypotheses
Volume 58, Issue 3 , Pages 225-228, March 2002